Abstract

<h3>Rationale</h3> Alveolar repair is critical to ARDS outcome. Myofibroblast induction is integral to healing by facilitating wound apposition (α-smooth muscle actin (α-SMA), secreting matrix (collagens 1 and 3), cytokines (TGF-β1 and connective tissue growth factor [CTGF]), and epithelial mitogens (keratinocyte growth factor [KGF]). We hypothesized that bronchoalveolar lavage fluid (BALF) from ARDS patients would induce multiple features of myofibroblasts. <h3>Methods</h3> ARDS BALF was collected within 48 hours of intubation. Patients with cardiogenic pulmonary edema were included as negative controls. ARDS and control BALF were incubated with normal human lung fibroblasts for 24 hours, and α-SMA, collagens 1 and 3, CTGF, TGF-β1, and KGF mRNA was measured by real-time RT-PCR. <h3>Results</h3> Ten ARDS patients and five negative controls were enrolled. The average age for ARDS patients was 53 ± 16 years. The average PaO<sub>2</sub>/ FiO<sub>2</sub> ratio, compliance, and APACHE 2 scores were 118 ± 70, 21 ± 10, and 28 ± 8, respectively. ARDS BALF induced 110% more α-SMA (<i>p</i> &lt; .05) and 85% more CTGF (<i>p</i> &lt; .05) than controls. In addition, ARDS BALF induced 43% more collagen 1 (<i>p</i> = .11) and 52% more collagen 3 (<i>p</i> = .08) than controls. In contrast, control BALF induced 70% more KGF (<i>p</i> &lt; .03) than ARDS BALF. There was a significant inverse correlation between ARDS induction of α-SMA and KGF (<i>r</i> = −.78, <i>p</i> &lt; .01). The TGF-β1 receptor inhibitor SB431542 significantly reduced ARDS BALF induction of α-SMA, CTGF, and collagens 1 and 3 (<i>p</i> &lt; .05 for all) but had no impact on KGF expression (<i>p</i> = .33). <h3>Conclusion</h3> Early ALI/ARDS BALF has predominant profibrotic characteristics and suppresses epithelial mitogen induction.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.